| Category | VC (N=36) | No VC (N=131) | p-value |
| Recipient gender Males Females |
34 (94.4%) 2 (5.6%) |
113 (86.3%) 18 (13.7%) |
> 0.05 |
| Donor gender Males Females |
25 (69.4%) 11 (30.6%) |
89 (67.9%) 42 (32.1%) |
> 0.05 |
| Co-morbidity | 14 (38.9%) | 47 (35.9%) | > 0.05 |
| Portal HTN | 34 (94.4%) | 126 (96.2%) | > 0.05 |
| Bl. Group Compatible Identical |
15 (41.7%) 21 (58.3%) |
33 (25.2%) 98 (74.8%) |
0.06 |
| Graft type Right lobe Left lobe |
35(97.2%) 1 (2.8%) |
124 (94.7%) 7 (5.3%) |
> 0.05 |
| HV anastomosis Single Multiple |
22 (61.1%) 14 (38.9%) |
93 (71%) 38 (29%) |
0.2 |
| PV anastomosis Single Multiple |
30 (83.3%) 6 (16.7%) |
125 (95.4%) 6 (4.6%) |
.01 |
| HA anastomosis Single Multiple |
35 (97.2%) 1 (2.8%) |
125 (95.4%) 6 (4.6%) |
> 0.05 |
| Preoperative PVT | 6 (16.7%) | 13 (9.9%) | 0.2 |
| Immunosuppression regimen Regimen including FK Regimen including Cyclosporine Regimen including Sirolomus |
34 (94.4%) 12 (33.3%) 4 (11.1%) |
110 (88%) 39 (29.8%) 15 (11.5%) |
> 0.05 |